Alison Finnegan - Concepedia

Author

Alison Finnegan

Rush University Medical Center

Also Known As

A Finnegan, A. Finnegan, A. W. Finnegan, ALISON FINNEGAN, Alison Finnegan

107

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center Presbyterian St. Luke's Medical Center National Cancer Institute Center for Rheumatology Bipar

About

Alison Finnegan is an author at Rush University Medical Center specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	28	1.9K
2	Allergy	12	12	772
3	Natural Sciences	3	3	280
4	Biochemistry	3	3	247
5	Public Health	1	1	54

Alison Finnegan

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide Xiulong Xu, James W. Williams, Eric G. Bremer, Journal of Biological Chemistry	1995	218
IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice Robert L. Hendricks, Terrence M. Tumpey, Alison Finnegan The Journal of Immunology	1992	193
Antigen-Specific B Cells Are Required as APCs and Autoantibody-Producing Cells for Induction of Severe Autoimmune Arthritis Shannon O’Neill, Mark J. Shlomchik, Tibor T. Glant, The Journal of Immunology	2005	186
REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1 Karyn F. Siemasko, Anita S. Chong, James W. Williams, Transplantation InflammationCytokineB Cell AntibodyMedicineHumoral Response	1996	185
The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms Robert T. Elder, Xiangbin Xu, J. W. Williams, The Journal of Immunology	1997	174
Inhibition of JAK3 and STAT6 Tyrosine Phosphorylation by the Immunosuppressive Drug Leflunomide Leads to a Block in IgG1 Production Karyn F. Siemasko, Anita S. Chong, Hans‐Martin Jäck, The Journal of Immunology Il-4 BindingImmunologyImmunologic MechanismImmunotherapyReceptor Tyrosine Kinase	1998	173
Cutting Edge: Regulation of T Cell Activation Threshold by CD28 Costimulation Through Targeting Cbl-b for Ubiquitination Jian Zhang, Tamás Bárdos, Dongdong Li, The Journal of Immunology	2002	168
IL-27 Induces a Th1 Immune Response and Susceptibility to Experimental Arthritis Yanxia Cao, Paul D. Doodes, Tibor T. Glant, The Journal of Immunology	2008	160
Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide Thomas Mattar, Kulvinder S. Kochhar, Robert Bartlett, FEBS Letters	1993	154
Th1 type lymphocyte reactivity to metals in patients with total hip arthroplasty Nadim J. Hallab, Marco S. Caicedo, Alison Finnegan, Journal of Orthopaedic Surgery and Research	2008	154

Page 1